id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-N-0266-0007,FDA,FDA-2010-N-0266,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Study of Clinical Efficacy Information in Professional Labeling, etc.; Correction",Notice,NCR-Notice of Correction,2010-12-23T05:00:00Z,2010,12,2010-12-23T05:00:00Z,,2010-12-23T15:27:48Z,2010-32278,0,0,0900006480bbea66
FDA-2010-N-0266-0005,FDA,FDA-2010-N-0266,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Study of ClinicalEfficacy Information in Professional Labeling and Direct-to-Consumer Print Advertisements for Prescription Drugs",Notice,N-Notice,2010-12-03T05:00:00Z,2010,12,2010-12-03T05:00:00Z,2011-01-04T04:59:59Z,2010-12-03T17:25:33Z,2010-30385,0,0,0900006480bad6f4
FDA-2010-N-0266-0001,FDA,FDA-2010-N-0266,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Study of Clinical Efficacy Information in Professional Labeling and Direct-to-Consumer Print Advertisements for Prescription Drugs",Notice,N-Notice,2010-06-16T04:00:00Z,2010,6,2010-06-16T04:00:00Z,2010-08-17T03:59:59Z,2010-10-29T01:11:39Z,2010-14445,0,0,0900006480b02bf8